PRADAXA
As listed in the register: PRADAXA
150 mg · capsule
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Dabigatran Etexilate (Dabigatran Etexilate Mesilate)
- Used in
- Blood, clotting and anaemia
- Made by
- Boehringer Ingelheim (Canada) Ltd Ltee
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria7 matching products
European UnionNo exact match for this strength and form
Spain29 matching products
- PRADAXA 150 mg · cápsula dura2 makers
- ANDABRA 150 mg · cápsula dura
- BIGETRA 150 mg · cápsula dura
- DABIDOSE 150 mg · cápsula dura
- DABIGATRAN DR REDDYS 150 mg · cápsula dura
- DABIGATRAN ETEXILATO ACCORD 150 mg · cápsula dura
- DABIGATRAN ETEXILATO ADAMED 150 mg · cápsula dura
- DABIGATRAN ETEXILATO ALTER GENERICOS 150 mg · cápsula dura
Netherlands15 matching products
- Dabigatran etexilaat Accord 150 mg harde capsules 150 mg · capsule, hard
- Dabigatran etexilaat Alembic 150 mg harde capsules 150 mg · capsule, hard
- Dabigatran etexilaat Biocon 150 mg harde capsules 150 mg · capsule, hard
- Dabigatran etexilaat Centrafarm 150 mg 150 mg · capsule, hard
- Dabigatran etexilaat CF 150 mg 150 mg · capsule, hard
- Dabigatran etexilaat Gedeon Richter 150 mg harde capsules 150 mg · capsule, hard
- Dabigatran etexilaat HCS 150 mg harde capsules 150 mg · capsule, hard
- Dabigatran etexilaat Reddy 150 mg harde capsules 150 mg · capsule, hard
SwitzerlandNo exact match for this strength and form
Details
| Made by | Boehringer Ingelheim (Canada) Ltd Ltee |
|---|---|
| Active substance | Dabigatran Etexilate (Dabigatran Etexilate Mesilate) |
| Used in | Blood, clotting and anaemia |
| Strength | 150 mg |
| Form | capsule |
| Classification | B01AE07 · Blood, clotting and anaemia |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02358808 |
| DPD drug code | 84384 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- capsule2 products
- 110 mg
- 150 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
See every product with Dabigatran Etexilate (Dabigatran Etexilate Mesilate)